AsymmetRx Ends Cancer Test IP Suit Against Dako
AsymmetRx Inc. and Harvard College have cut a deal with Danish drugmaker Dako Denmark A/S while in arbitration proceedings that resolves their infringement suit in district court over patents related to...To view the full article, register now.
Already a subscriber? Click here to view full article